News

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.
    11/09/2023

NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conference Call Participants Marta Nazarovets - JPMorgan Kyle Boucher - TD Cowen Catherine Schulte - Baird Evan Stampler - Stifel Alexander Vukasin - Canaccord Genuity Operator Good afternoon. My name is Krista and I'll be your conference operator today.
    11/06/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

NanoString Technologies, Inc. (NSTG) can buy. Click on Rating Page for detail.

The price of NanoString Technologies, Inc. (NSTG) is 0.5544 and it was updated on 2023-12-02 07:00:44.

Currently NanoString Technologies, Inc. (NSTG) is in undervalued.

News
    
News

NanoString (NSTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

  • While the top- and bottom-line numbers for NanoString (NSTG) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
    Mon, Nov. 06, 2023

Short squeeze alert for October 18th: 2 stocks that could soar

  • In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their price dropping to make a profit.
    Wed, Oct. 18, 2023

NanoString (NSTG) Grows in Translational Research With CRO Deals

  • According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.
    Tue, Sep. 12, 2023

NanoString (NSTG) Advances in Xenotransplantation With New Study

  • NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through the nCounter Human Organ Transplant Panel.
    Wed, Aug. 23, 2023

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord Global Growth Conference Wednesday, August 9th Tom Bailey, NanoString's chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Canaccord.
    Tue, Aug. 08, 2023
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

NanoString Technologies, Inc. (NSTG) Q2 2023 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations & Corporate Communications Brad Gray - President & Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants John Sourbeer - UBS Tom Peterson - Baird Operator Thank you for standing by. My name is Ian, and I will be your conference operator today.
  • 08/03/2023

Helen of Troy and NanoString Technologies Trade Set-ups

  • The action is hot in Helen Of Troy NASDAQ: HELE and NanoString Technologies NASDAQ: NSTG. These unrelated companies issued better-than-expected results and guidance that have their shares up double-digits in early trading.
  • 07/10/2023

Red-Hot Quality Opportunities in Genomics

  • The health care sector is currently undergoing a remarkable transformation. The recent focus on genomics has empowered medical professionals to diagnose patients more objectively and adopt proactive measures to maintain the well-being of larger populations.
  • 06/22/2023

NanoString to Webcast Presentation from Jefferies Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Thursday, June 8, 2023, at 8:30am ET. Interested parties can access the live webcast from the investor section o.
  • 05/31/2023

NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich. Investors and other interested parties should register for the conference call in advance by visiting https://www.netroadshow.com/events/login?show=9b96aaa1&confId=5.
  • 05/22/2023

Why Shares of NanoString Technologies Are Falling Thursday

  • NanoString Technologies may have to stop selling certain instruments and reagents in Germany. The company said it plans to appeal the ruling.
  • 05/18/2023

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

  • NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.
  • 05/03/2023

NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023

  • SEATTLE--(BUSINESS WIRE)--NanoString to report Q1 2023 operating results on May 3, 2023.
  • 04/10/2023

NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
  • 03/01/2023

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 02/28/2023

NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Tuesday, March 7, 2023, at 1:30pm ET.
  • 02/23/2023

NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
  • 02/14/2023

NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference

  • SEATTLE--( BUSINESS WIRE )--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company's management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.
  • 12/22/2022

NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
  • 11/10/2022

NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -71.74% and 16.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/07/2022

NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report third quarter 2022 operating results after the close of the market on Monday, November 7, 2022.
  • 10/12/2022

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming financial conferences. Morgan Stanley 20th Annual Global Healthcare Conference Monday, September 12th Brad Gray, NanoString's chief executive officer, will participate in a fireside discussion at 1:05pm ET. 2022 Baird Global Healthcare Conference Tu
  • 09/07/2022

NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations Brad Gray - President and Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Genuity Dan Brennan - Cowen Edmund Debler - Morgan Stanley Dan Arias - Stifel Operator Hello and welcome to the NanoString Second Quarter Operating Results. My name is Katie, and I'll be coordinating your call today.
  • 08/06/2022

NanoString Technologies (NSTG) Reports Q2 Loss, Lags Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -37.10% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 08/04/2022

NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 42nd Annual Canaccord Global Growth Conference Wednesday, August 10th Brad Gray, NanoString's chief executive officer, will participate in a spatial biology panel titled, “The New Frontier of Life Sciences: Spatial Omics is T
  • 08/04/2022

Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?

  • The consensus price target hints at a 171.7% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  • 07/21/2022

NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference cal
  • 07/11/2022

NanoString to Webcast Presentation from the UBS 2022 Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, May 25, 2022, at 9:15 am ET. Interested parties can access the live webcast with accompanying slides from the investor section of
  • 05/18/2022

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2022 Earnings Call Transcript

  • NanoString Technologies, Inc. Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Doug Farrell - VP of IR & Corporate Communications Brad Gray - CEO, President & Director Tom Bailey - CFO Conference Call Participants Daniel Brennan - Cowen Dan Arias - Stifel Julia Qin - JPMorgan Kyle Mikson - Canaccord Genuity Catherine Schulte - Robert W. Baird Tejas Savant - Morgan Stanley Operator Hello.
  • 05/10/2022

NanoString to Release First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2022 operating results after the close of the market on Tuesday, May 10, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference call in
  • 04/27/2022

NanoString stock plunges after revenue warning, but analyst says selloff appears 'way overdone'

  • Shares of NanoString Technologies Inc. ntsg plunged 32.8% toward a two-year low in morning trading Wednesday, enough to make them the biggest losers trading on major U.S. exchanges, after the provider of life science discovery tools warned about a revenue miss, citing execution missteps. The company said late Tuesday that it now expects first-quarter product and service revenue of $31 million, below the previously provided guidance range of $34 million to $38 million.
  • 04/13/2022

Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?

  • The mean of analysts' price targets for NanoString (NSTG) points to an 116.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
  • 04/06/2022

NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript

  • NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript
  • 03/01/2022

NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at 11th Annual SVB Leerink Healthcare Conference.
  • 02/09/2022

NanoString Expects Q4 Product And Service Revenue Growth Of 18%

  • NanoString Technologies Inc (NASDAQ: NSTG) expects Q4 FY21 product and service revenue of approximately $42 million, +18% Y/Y and at the upper end of the company's guidance of $38 million - $42 million. For FY21, the company expects product and service revenue to be approximately $144 million, +29% YY and at the upper end of the company's prior guidance of $140 million - $144 million.
  • 01/10/2022

NanoString Technologies' Q3 Fall Short Street View; Cuts FY21 Guidance

  • NanoString Technologies Inc (NASDAQ: NSTG) reported Q3 sales of $37.15 million, +17% Y/Y, mainly driven by instrument sales, demand for consumables, and services. Q3 sales fell slightly short of analysts' consensus estimate of $37.79 million.
  • 11/10/2021

NanoString to Webcast Presentation from the Stifel 2021 Virtual Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at the 2021 Stifel Virtual Healthcare Conference.
  • 11/10/2021

NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript

  • NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript
  • 11/09/2021

NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments

  • SEATTLE--(BUSINESS WIRE)--NanoString announces the launch of the nCounter® ADC Development Panel.
  • 10/12/2021

NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021

  • SEATTLE--(BUSINESS WIRE)--NanoString to host third quarter 2021 operating results webcast on Tuesday, November 9th, 2021.
  • 10/06/2021

NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at Morgan Stanley Global Healthcare Conference.
  • 09/01/2021

NanoString's GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell

  • SEATTLE--(BUSINESS WIRE)--NanoString announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
  • 08/31/2021

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript

  • NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
  • 08/04/2021

NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021

  • SEATTLE--(BUSINESS WIRE)--NanoString to report second quarter 2021 operating results and host conference call on Wednesday, August 4th.
  • 07/08/2021

NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics. Recent breakthroughs in stem cell therapy, regenerative medicine, and CRISPR engineering have advanced the development of promising new treatments for debili
  • 06/22/2021

NanoString: Compelling Upside For This Spatial Biology Instrument Developer

  • NanoString Technologies, Inc. is a genomics/proteomics-focused developer of advanced instruments and consumables for scientific and clinical research. NanoString's products consist of two commercially available product platforms, the nCounter Analysis System (launched in 2008) and the GeoMx Digital Spatial Profiler System ("DSP" launched in 2019).
  • 06/17/2021

NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer

  • SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy (PICI) announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens tha
  • 06/15/2021

NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.
  • 05/27/2021

Down More Than 20%, Is This Cathie Wood Biotech A Buy?

  • 10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
  • 05/20/2021

NanoString to Webcast Presentation from the UBS Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the UBS Global Healthcare Conference.
  • 05/20/2021

NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the Mouse Whole Transcriptome Atlas (WTA) for spatial analysis research using the GeoMx® Digital Spatial Profiler (DSP). This launch extends the GeoMx RNA portfolio, which combines the power of spatial biology and Next Generation Sequencing (NGS), to enable full transcriptome spatial RNA and high
  • 05/17/2021

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript

  • NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript
  • 05/11/2021

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -6.90% and 5.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 05/10/2021

Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

  • The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
  • 05/07/2021

NanoString's Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19

  • SEATTLE--(BUSINESS WIRE)--NanoString announced today that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler is to be published in the journal Nature.
  • 05/04/2021

NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString announces spatial biology highlights from the 2021 American Association of Cancer Research Conference.
  • 04/08/2021

NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications

  • SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP reveals insights into COVID-19 in two new publications in Nature.
  • 03/31/2021

Top Shorts Today As Stocks Recover From Yesterday's Sell-Off

  • After the market sold off on the first anniversary of the bull market yesterday, investors saw renewed signs of recovery. Meanwhile, the deep learning algorithms at Q.ai have crunched the data to give you today's top shorts.
  • 03/24/2021

NanoString, Illumina Accelerator and Doloromics Announce GeoMx Digital Spatial Profiling Collaboration to Develop Novel Pain Therapeutics

  • SEATTLE--(BUSINESS WIRE)-- #spatialbiology--NanoString enters spatial biology collaboration with Illumina Accelerator and Doloromics.
  • 03/22/2021

Top Stocks To Short Today As Nasdaq Pops Again

  • Just as quickly as Nasdaq NDAQ hit correction territory twice in the last week, it saw sharp gains. Meanwhile, Q.ai's deep learning algorithms have brought you today's top shorts.
  • 03/11/2021

NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021.
  • 03/09/2021

Top Stocks To Short Today As The Rotation Into Recovery Continues

  • The rotation into recovery continues as President Biden's stimulus proposal passed through the Senate. To make the most of this market, Q.ai's Artificial Intelligence has assessed each firm to find today's top short plays.
  • 03/08/2021

NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q4 2020 Results - Earnings Call Transcript

  • NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q4 2020 Results - Earnings Call Transcript
  • 03/02/2021

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -12.77% and 1.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 03/01/2021

NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook

  • SEATTLE--(BUSINESS WIRE)--NanoString releases Q4 and FY20 operating results.
  • 03/01/2021

NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.
  • 03/01/2021

A Preview Of NanoString Technologies's Earnings

  • NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for NanoString Technologies's Q4 earnings.
  • 02/26/2021

NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.
  • 02/24/2021

Earnings Preview: NanoString Technologies (NSTG) Q4 Earnings Expected to Decline

  • NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 02/22/2021

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

  • SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.
  • 02/22/2021

NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at 10th Annual SVB Leerink conference.
  • 02/17/2021

Nature Medicine Publishes First Study Utilizing NanoString's GeoMx Digital Spatial Profiler Whole Transcriptome Atlas

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that used NanoString's GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mecha
  • 02/09/2021

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020

  • SEATTLE--(BUSINESS WIRE)--NanoString provides preliminary financial and operational highlights for Q4'20.
  • 01/10/2021

NanoString's GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications

  • SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP Identifies Diverse Immune Responses in COVID-19 Patients.
  • 12/09/2020

NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology

  • SEATTLE--(BUSINESS WIRE)--NanoString announces development of spatial molecular imaging platform.
  • 12/01/2020

NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)

  • SEATTLE--(BUSINESS WIRE)--NanoString announces research highlights from SITC 2020.
  • 11/11/2020

NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q3 2020 Results - Earnings Call Transcript

  • NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q3 2020 Results - Earnings Call Transcript
  • 11/10/2020

NanoString Technologies: Q3 Earnings Insights

  • Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 1.56% over the past year to ($0.65), which missed the estimate of ($0.60).
  • 11/09/2020

NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing

  • SEATTLE--(BUSINESS WIRE)--NanoString announces commercial launch of spatially resolved protein analysis using next generation sequencing.
  • 11/09/2020

K Thomas Bailey Sells 5,938 Shares of NanoString Technologies Inc (NASDAQ:NSTG) Stock

  • NanoString Technologies Inc (NASDAQ:NSTG) CFO K Thomas Bailey sold 5,938 shares of NanoString Technologies stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $38.94, for a total transaction of $231,225.72. Following the sale, the chief financial officer now directly owns 5,938 shares of the company’s stock, valued […]
  • 08/22/2020

10x Genomics Enjoys Investor Support As Stock Rebounds

  • 10x Genomics went public in September 2019. The firm provides equipment and software for genetic research purposes.
  • 08/14/2020

Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment?

  • Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
  • 08/11/2020

Did You Miss NanoString Technologies' (NASDAQ:NSTG) Impressive 151% Share Price Gain?

  • It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
  • 08/11/2020

NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -28.57% and 40.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 08/10/2020

NanoString Technologies Releases Operating Results for Second Quarter of 2020

  • NanoString Technologies Releases Operating Results for Second Quarter of 2020
  • 08/10/2020

NanoString Technologies Releases Operating Results for Second Quarter of 2020

  • NanoString Technologies Releases Operating Results for Second Quarter of 2020
  • 08/10/2020

NanoString Technologies Inc (NASDAQ:NSTG) Expected to Announce Quarterly Sales of $16.15 Million

  • Analysts expect NanoString Technologies Inc (NASDAQ:NSTG) to post $16.15 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for NanoString Technologies’ earnings, with estimates ranging from $13.66 million to $18.78 million. NanoString Technologies reported sales of $30.35 million in the same quarter last year, which would suggest […]
  • 08/09/2020

Medical Products Stock Earnings on Aug 10: CGC, SDGR & More

  • Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.
  • 08/07/2020

NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

  • NanoString Expands RNAscope Partnership with Bio-Techne's ACD Division.
  • 08/06/2020

NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

  • NanoString Expands RNAscope Partnership with Bio-Techne's ACD Division.
  • 08/06/2020

Were Hedge Funds Right About Buying NanoString Technologies Inc (NSTG)?

  • The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
  • 08/05/2020

Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know

  • NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 08/03/2020

NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers

  • NanoString announces next generation sequencing read-out for the GeoMx Digital Spatial Profiler.
  • 08/03/2020

NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers

  • NanoString announces next generation sequencing read-out for the GeoMx Digital Spatial Profiler.
  • 08/03/2020

NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020

  • NanoString Announces Second Quarter Conference Call
  • 07/08/2020

NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020

  • NanoString Announces Second Quarter Conference Call
  • 07/08/2020

NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher

  • NanoString Technologies (NSTG) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
  • 07/02/2020

Global Digital Genome Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Application, End-user, Geography and Company - ResearchAndMarkets.com

  • The
  • 06/29/2020

Hedge Funds Getting Crazy About NanoString Technologies Inc (NSTG)

  • At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]
  • 06/23/2020

Two Sigma Investments LP Has $1.23 Million Stake in NanoString Technologies Inc (NASDAQ:NSTG)

  • Two Sigma Investments LP grew its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 12.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,247 shares of the biotechnology company’s stock after purchasing an additional 5,687 shares during the period. Two Sigma Investments LP […]
  • 06/22/2020

Arch Oncology Announces Formation of Scientific Advisory Board

  • Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies,
  • 06/22/2020

NanoString Technologies Inc (NASDAQ:NSTG) Shares Purchased by Nuveen Asset Management LLC

  • Nuveen Asset Management LLC boosted its holdings in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 107.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 553,845 shares of the biotechnology company’s stock after acquiring an additional 286,968 shares during the […]
  • 06/20/2020

NanoString Technologies : Announces New Products to Advance COVID-19 Disease Research | MarketScreener

  • 06/16/2020

NanoString Announces New Products to Advance COVID-19 Disease Research

  • NanoString announces new COVID-19 research tools.
  • 06/16/2020

NanoString Announces New Products to Advance COVID-19 Disease Research

  • NanoString announces new COVID-19 research tools.
  • 06/16/2020

Edited Transcript of NSTG earnings conference call or presentation 7-May-20 8:30pm GMT

  • Q1 2020 NanoString Technologies Inc Earnings Call
  • 06/10/2020

Acadian Asset Management LLC Sells 86,291 Shares of NanoString Technologies Inc (NASDAQ:NSTG)

  • Acadian Asset Management LLC decreased its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 96.6% in the 1st quarter, HoldingsChannel reports. The fund owned 3,069 shares of the biotechnology company’s stock after selling 86,291 shares during the period. Acadian Asset Management LLC’s holdings in NanoString Technologies were worth $74,000 as of its most recent […]
  • 06/10/2020

Global Precision Medicine Market Report 2020: Historic Analysis and Outlook 2015-2025 - ResearchAndMarkets.com

  • The
  • 05/25/2020

NanoString, OnRamp Reports Partnership To Develop Cloud-Based Analysis Solutions For nCounter Data

  • 05/20/2020

NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data

  • NanoString and OnRamp Partner to Develop Cloud-Based Analysis Solutions for nCounter Data.
  • 05/20/2020

21 Risky Stocks That Might Have Borrowed More Than Is Good For Them

  • Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause problems down the road.
  • 05/19/2020

21 Stocks That Might Have Borrowed More Than Is Good For Them

  • Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause problems down the road
  • 05/19/2020

NanoString to Present at the UBS Global Healthcare Conference

  • NanoString to present at the UBS Global Healthcare Conference.
  • 05/14/2020

CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System

  • CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
  • 05/14/2020

Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research

  • NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
  • 05/12/2020

Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research

  • NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
  • 05/12/2020

NanoString to Present at the Bank of America Health Care Conference

  • NanoString to present at the Bank of America Health Care Conference.
  • 05/11/2020

NanoString to Present at the Bank of America Health Care Conference

  • NanoString to present at the Bank of America Health Care Conference.
  • 05/11/2020

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2020 Results - Earnings Call Transcript

  • Start Time: 16:30 End Time: 17:21 NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2020 Earnings Conference Call May 07, 2020, 16:30 PM ET Company Participants Br
  • 05/10/2020

Nanostring Technologies (NSTG) Q1 2020 Earnings Call Transcript

  • Ladies and gentlemen, thank you for standing by, and welcome to the NanoString first-quarter 2020 operating results conference call. Joining me on the call today is Brad Gray, our president and CEO; and Tom Bailey, our CFO.
  • 05/09/2020

Edited Transcript of NSTG earnings conference call or presentation 7-May-20 8:30pm GMT

  • Q1 2020 NanoString Technologies Inc Earnings Call
  • 05/08/2020

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -34.69% and 7.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 05/07/2020

NanoString Technologies Q1 EPS $(1.040) May Not Compare To $(0.520) Estimate, Sales $24.500M Miss $25.420M Estimate

  • 05/07/2020

NanoString Technologies Releases Operating Results for First Quarter of 2020

  • NanoString reports first quarter 2020 operating results.
  • 05/07/2020

What will the Oracle say?

  • News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
  • 05/01/2020

NanoString Technologies Inc (NASDAQ:NSTG) Receives $33.25 Consensus PT from Brokerages

  • NanoString Technologies Inc (NASDAQ:NSTG) has been given an average rating of “Buy” by the six brokerages that are presently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokerages that have […]
  • 05/01/2020

Columbus Circle Investors Increases Stock Holdings in NanoString Technologies Inc (NASDAQ:NSTG)

  • Columbus Circle Investors lifted its position in NanoString Technologies Inc (NASDAQ:NSTG) by 1,082.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 262,704 shares of the biotechnology company’s stock after buying an additional 240,480 shares during the quarter. Columbus […]
  • 04/30/2020

UBS Maintains Buy on NanoString Technologies, Lowers Price Target to $38

  • 04/28/2020

Stock Upgrades: NanoString Technologies Shows Rising Relative Strength

  • 0